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Transgene variegation modifiers <p>An extended ENU screen for modifiers of transgene variegation identified four new modifiers, MommeD7-D10.</p>
Abstract
Background: Some years ago we established an N-ethyl-N-nitrosourea screen for modifiers of
transgene variegation in the mouse and a preliminary description of the first six mutant lines, named
MommeD1-D6, has been published. We have reported the underlying genes in three cases:
MommeD1 is a mutation in SMC hinge domain containing 1 (Smchd1), a novel modifier of epigenetic
gene silencing; MommeD2 is a mutation in DNA methyltransferase 1 (Dnmt1); and MommeD4 is a
mutation in Smarca 5 (Snf2h), a known chromatin remodeler. The identification of Dnmt1 and
Smarca5 attest to the effectiveness of the screen design.
Results: We have now extended the screen and have identified four new modifiers, MommeD7-
D10. Here we show that all ten MommeDs link to unique sites in the genome, that homozygosity
for the mutations is associated with severe developmental abnormalities and that heterozygosity
results in phenotypic abnormalities and reduced reproductive fitness in some cases. In addition, we
have now identified the underlying genes for MommeD5 and MommeD10. MommeD5 is a mutation
in Hdac1, which encodes histone deacetylase 1, and MommeD10 is a mutation in Baz1b (also known
as Williams syndrome transcription factor), which encodes a transcription factor containing a PHD-
type zinc finger and a bromodomain. We show that reduction in the level of Baz1b in the mouse
results in craniofacial features reminiscent of Williams syndrome.
Conclusions:  These results demonstrate the importance of dosage-dependent epigenetic
reprogramming in the development of the embryo and the power of the screen to provide mouse
models to study this process.
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Background
Random mutagenesis screens for modifiers of position effect
variegation were initiated in Drosophila in the 1960s [1,2].
The screens used a fly strain, called wv, that displays varie-
gated expression of the white (w) locus resulting in red and
white patches in the eye. Variegation refers to the 'salt and
pepper' expression of some genes due to the stochastic estab-
lishment of an epigenetic state at their promoters. The best
characterized example of variegation in mammals is the coat
color of mice carrying the Avy allele [3,4]. In this case there is
a correlation between DNA methylation at the promoter and
silencing of the gene [5,6]. Alleles of this type provide us with
an opportunity to study epigenetic gene silencing at a molec-
ular level in a whole organism.
The extent of the variegation at the wv locus, that is, the ratio
of red to white patches in the eye, was known to be sensitive
to strain background, suggesting the existence of genetic
modifiers. Offspring of mutagenized flies were screened for
changes in the degree of variegation. These screens have been
continued to saturation and the results suggest that there are
between 100 and 150 such genes [7,8]. Approximately one-
third of these have been identified and, as expected, most turn
out to play critical roles in epigenetic gene silencing [1,9].
These include genes encoding proteins involved in hetero-
chromatin formation, for example, HP1 and histone methyl-
transferases [8].
Recently, we established a similar screen in the mouse using
a transgenic line that expresses green fluorescent protein
(GFP) in a variegated manner in erythrocytes [10]. We antic-
ipated that the screen would produce mutant lines that would
help clarify the role of epigenetic gene silencing in mammals.
Offspring of N-ethyl-N-nitrosourea (ENU) treated males
were screened for changes in the percentage of erythrocytes
expressing GFP (measured by flow cytometry). In those indi-
viduals in which the percentage of expressing cells was higher
or lower than the wild-type mean by more than two standard
deviations, heritability was tested. A preliminary description
of the first six heritable mutations, which we refer to as Mod-
ifiers of murine metastable epialleles or Mommes, following
the screening of 608 G1 offspring, has been published [10].
We reported that all six were dosage-effect genes and five of
the six were homozygous lethal, with loss of homozygotes
apparent at weaning, but no knowledge of when death
occurred. At the time of publication in 2005, none of the
underlying genes had been identified. Since then we have
identified the underlying mutation in three cases, MommeD1,
MommeD2 and MommeD4. MommeD1 is a mutation in SMC
hinge domain containing 1 (SmcHD1), encoding a previously
uncharacterized protein containing a domain normally found
in SMC proteins and we have gone on to show that this pro-
tein has a critical role in X inactivation [11]. MommeD2 is a
mutation in DNA methyltransferase 1, Dnmt1, encoding a
DNA methyltransferase, and MommeD4  is a mutation in
Smarca5, encoding Snf2h, a chromatin-remodeling enzyme
[12]. The finding of Dnmt1 and Smarca5, both known to be
involved in epigenetic reprogramming, validates the screen.
Here we report an update of the screen, adding four new
MommeDs, identifying the underlying point mutation in two
more cases, and further characterizing the phenotypes associ-
ated with hetero- and homozygosity.
Results and discussion
Integration site of the GFP transgene
We have previously reported that the GFP transgene used in
this screen has integrated as an approximately 11 copy array
on chromosome 1 [10]. We were keen to further characterize
the integration site. PCR using primers specific to the 3' end
of the transgene construct in combination with degenerate
random tagging primers (genome walking) revealed that the
transgene had integrated into chromosome 1 at 47,747,486
bp (UCSC web browser, July 2007 assembly). This site of
integration is neither centromeric nor telomeric, and so pre-
sumably the silencing is related to the multicopy nature of the
transgene array [13,14]. The integration site does not disrupt
any annotated genes, and is approximately 1 Mb from the
closest annotated transcript.
The identification of MommeD7-D10
We have now screened an additional 400 G1 offspring and
recovered four more Mommes,  MommeD7-D10  (Figure 1,
Table 1). The fluorescence activated cell sorting (FACS)-based
screening is carried out on a drop of blood taken at weaning,
using a gate set to exclude 99.9% of autofluorescing cells.
Under these conditions, wild-type mice homozygous for the
transgene express GFP in 55% of erythrocytes. MommeD7 is
a suppressor of variegation, that is, the percentage of cells
expressing the transgene was significantly higher than it was
in wild-type individuals (Table 1). MommeD8, D9 and D10
are enhancers of variegation, that is, the percentages of
expressing cells were significantly lower than they were in
wild-type individuals (Table 1). The mean fluorescence level
in expressing cells also changed. We have reported previously
that as the percentage of expressing cells increases, the mean
fluorescence of the expressing cells increases [10]. We pre-
sume that since the mice are homozygous for the GFP trans-
gene, this is mainly due to an increase in the proportion of
expressing cells with two active GFP alleles. However, in the
case of MommeD7 the level was more than double that seen
in the wild-type littermates. We hypothesized that this was
likely to be the consequence of an increase in the percentage
of reticulocytes in the peripheral blood of this mutant, as
mature red cells, with no ability to produce new proteins,
would have, on average, less GFP than reticulocytes (see
below). In the cases of MommeD8, D9 and D10 the mean flu-
orescence levels were slightly lower than that seen in the wild-
type littermates, consistent with a presumed reduction in the
proportion of cells with two active GFP alleles.http://genomebiology.com/2008/9/12/R182 Genome Biology 2008,     Volume 9, Issue 12, Article R182       Ashe et al. R182.3
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For each MommeD, the heritability of the mutation has been
tested and confirmed over at least 5 generations by using at
least 30 litters. During the breeding of each mutant line, the
expression profiles remained constant, consistent with the
idea that we were following a single mutation in each case.
The frequency with which we found these mutations, 1 in 100
G1 offspring, was similar to our previous results [10].
Homozygous lethality
Following heterozygous intercrosses, the proportion of
expression types observed in the offspring at weaning was
consistent with a semidominant homozygous lethal mutation
in the cases of MommeD7 and MommeD9, since only two
GFP expression profiles were observed (Figure 1, Tables 1 and
2) and there was a significant litter size reduction in both
cases (Figure 2). In the cases of MommeD8 and MommeD10,
three expression profiles were observed, suggesting viability
of some homozygotes (Figure 1, Tables 1 and 2) and in the
case of MommeD10 this was later confirmed by genotyping
for the point mutation. In both cases, fewer individuals with
the severe phenotypes were observed than predicted by Men-
delian inheritance, suggesting reduced viability of the
homozygotes (Table 2). This conclusion is supported by sig-
nificant litter size reductions in both cases (Figure 2). There is
also a suggestion of some heterozygous death in the case of
MommeD8 and, to a lesser extent, MommeD10 but this is not
statistically significant.
Homozygous lethality occurs at different stages of 
development
Litter size reductions following heterozygous intercrosses
have already been reported for MommeD1-D6  at weaning
[10], but the timing of the losses has only been reported for
MommeD1, D2 and D4. MommeD1 is homozygous lethal in
females only, with death occurring around mid-gestation
[10,11]. MommeD2 and MommeD4 are homozygous lethal at
8.5 days post-coitus (dpc) and 17.5 dpc, respectively [10,12].
Here we describe the timing of the losses for MommeD3, D5,
D6, D7, D8, D9 and D10.
Following intercrosses between MommeD3-/+  (genotypes
determined by GFP fluorescence and progeny testing), dis-
sections at 14.5 dpc suggested that death of homozygotes had
already occurred (Table 3). This was confirmed following a
FVB/C57 F1 MommeD3-/+ intercross, where embryos could be
genotyped using microsatellite markers across the linked
interval (Table 3). These data suggest MommeD3-/- mice were
dying at or before 14.5 dpc. Similar results were obtained for
GFP expression profiles in MommeD7-D10 Figure 1
GFP expression profiles in MommeD7-D10. Erythrocytes from 3-week-old mice were analyzed by flow cytometry. In each case, the expression 
profiles from one litter of a heterozygous intercross are displayed. The phenotypically wild-type mice are shown in black, heterozygotes in dark grey, and 
homozygotes (MommeD8 and D10 only) in light grey. The x-axis represents the erythrocyte fluorescence on a logarithmic scale, and the y-axis is the 
number of cells detected at each fluorescence level. For quantitative and statistical significance, see Table 1.
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Table 1
Quantitative analysis of GFP expression following heterozygous intercrosses
Percentage expressing cells Mean fluorescence
Mutant WT (n) Heterozygote (n) Homozygote (n) WT (n) Heterozygote (n) Homozygote (n)
MommeD7 55 ± 7 (7) 80 ± 3* (13) NA 286 ± 43 (7) 700 ± 52* (13) NA
MommeD8 54 ± 4 (40) 41 ± 4* (55) 15 ± 4* (15) 287 ± 25 (40) 244 ± 28* (55) 161 ± 27* (15)
MommeD9 59 ± 4 (8) 39 ± 6* (13) NA 326 ± 37 (8) 228 ± 27* (13) NA
MommeD10 55 ± 4 (46) 44 ± 3* (87) 22 ± 2* (6) 295 ± 33 (46) 269 ± 26* (87) 243 ± 19* (6)
The percentage of expressing cells was determined by using a GFP+ gate, which was set to exclude 99.9% of wild-type (WT) cells. Data were 
collected from at least four litters in each case. The data for the MommeD9 colony were collected using a different laser. Each mutant line has a 
significantly different expression profile to that of wild-type littermates, reproducible over many generations. *p  0.0001.http://genomebiology.com/2008/9/12/R182 Genome Biology 2008,     Volume 9, Issue 12, Article R182       Ashe et al. R182.4
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MommeD5 at 14.5 dpc (Table 3). Once the MommeD5 point
mutation had been found (see below), these crosses were
repeated and dissections were performed at 10.5 dpc. Again,
a significantly higher than expected proportion of develop-
mentally delayed embryos were detected (Table 3). These
embryos were genotyped and found to be MommeD5-/- in all
cases, indicating developmental arrest at around 8-9 dpc.
Results obtained for MommeD6 (genotypes determined by
GFP fluorescence and progeny testing) were similar (Table 3),
suggesting MommeD6-/- embryos arrest around 8-9 dpc.
Following MommeD7-/+ intercrosses (genotypes determined
by GFP fluorescence and progeny testing), a small but signif-
icant increase in abnormal embryos was detected at 14.5 dpc
(Table 3). This increase is not enough to account for all
expected MommeD7-/- mice. At 17.5 dpc, approximately one-
quarter of the embryos were pale (Table 3, Figure 3a), sug-
gesting a red cell defect in the homozygotes. Homozygous
MommeD7 mutants were never seen at weaning (Table 2),
and preliminary observations suggest that they die in the first
few days after birth. Further analysis of adult heterozygous
individuals revealed severe splenomegaly (Figure 3b) and a
marked increase in reticulocytes in peripheral blood (Figure
3c).
We hypothesized that this increase in reticulocytes was
responsible for the larger than expected increase in the aver-
age fluorescence level of the GFP transgene in expressing cells
observed in this line (Table 1). We performed FACS analysis
on whole blood after staining for reticulocytes with propid-
ium iodide. As expected, MommeD7-/+ mice had a threefold
increase in the percentage of reticulocytes compared to
MommeD7+/+ mice (Figure 3d), and the percentage of GFP
fluorescence in both MommeD7-/+  and  MommeD7+/+  was
higher in reticulocytes than mature red cells (Figure 3e).
Litter size at weaning following heterozygous intercrosses Figure 2
Litter size at weaning following heterozygous intercrosses. Litter 
size at weaning in all of MommeD7-D10 is significantly lower than that 
found in a wild-type (WT) cross. n represents the number of litters. *p < 
0.05; **p < 0.001.
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Table 2
Genotype ratios of offspring at weaning following heterozygous intercrosses
Observed Expected if semidominant, homozygous viable Expected if semidominant, homozygous lethal
MommeD7
Heterozygote* 65 60
Wild type 25 30
MommeD8
Homozygote* 14 27.5
Heterozygote* 56 55
Wild type 40 27.5
MommeD9
Heterozygote* 31 37.3
Wild type 25 18.7
MommeD10
Homozygote* † 14 77.25
Heterozygote* † 187 154.5
Wild type 108 77.25
Offspring were classified as wild type, heterozygous or homozygous based on their GFP expression profiles. p-values: MommeD7, not significant; 
MommeD8, p < 0.005; MommeD9, not significant; MommeD10, p < 0.0001. *Progeny testing of mice classified based on GFP expression was carried 
out in a number of cases: 5 for MommeD7-/+, 11 for MommeD8-/-, 16 for MommeD8-/+, 8 for MommeD9-/+, 6 for MommeD10-/- and 11 for MommeD10-
/+. In all cases the genotype was as expected. †Presumed genotype was confirmed by genotyping for 8 MommeD10-/- and 79 MommeD10-/+ mice.http://genomebiology.com/2008/9/12/R182 Genome Biology 2008,     Volume 9, Issue 12, Article R182       Ashe et al. R182.5
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Although this is only significant for MommeD7-/+ (p < 0.005),
the trend is there for MommeD7+/+ mice (p = 0.07). This is
consistent with the idea that a change in the erythroid cell
populations contributes to the dramatic increase in the aver-
age fluorescence level of the GFP transgene in MommeD7-/+
mice.
Some MommeD8-/- mice (classified by their GFP expression
profile and progeny testing) were viable at weaning but they
were rare (Figure 1, Table 2). Following MommeD8-/+ inter-
crosses, dissections at 14.5 dpc showed no increase in the
number of abnormal or resorbed embryos (Table 3). Litter
size at birth was not significantly different from that seen in
wild-type litters (data not shown), suggesting that the death
of most MommeD8-/- individuals occurred after birth and
before weaning. The only obvious phenotypic abnormality
seen in MommeD8-/- mice that survived to weaning was
reduced size. MommeD8  homozygotes were significantly
smaller (6.60 g ± 0.25 standard error of the mean (SEM))
than their wild-type (8.54 g ± 0.33 SEM, p < 0.001) and het-
erozygous (8.65 g ± 0.29 SEM, p < 0.0001) littermates.
Dissections following MommeD9-/+ (determined by GFP flu-
orescence and progeny testing) intercrosses revealed a pat-
tern similar to that seen for MommeD5  and  MommeD6,
suggesting MommeD9-/- embryos arrest before 9.5 dpc (Table
3). In the case of MommeD10 the data suggest that death of
homozygotes occurred after birth (Table 3), and preliminary
data collected at P7 indicated death in the first week of life
(data not shown). Some MommeD10-/- individuals survived
to weaning but they were extremely rare. This was confirmed
by genotyping once the point mutation was identified.
So in all ten MommeDs produced so far, homozygosity for the
mutation is associated with embryonic or perinatal lethality
(Tables 3 and 4).
Abnormal phenotypes associated with heterozygosity 
for MommeD7-D10
Extensive phenotyping of the heterozygous MommeD mutant
lines has not been carried out. However, in some cases heter-
ozygous effects were obvious, for example, the haematopoi-
etic defect in MommeD7-/+ mice described above. We have
also noticed some litter size reduction during the breeding of
these strains. The data for the breeding of MommeD7, D8, D9
and D10 are shown in Figure 4. Following crosses between
heterozygous males and wild-type females in the FVB strain,
we found significant litter size reductions in the cases of
MommeD9  and  MommeD10, but not in the cases of
MommeD7 and MommeD8. A breakdown of the offspring by
sex and genotype revealed that for MommeD9  and
MommeD10, the litter size reduction was associated with a
deviation from Mendelian patterns of inheritance (p < 0.05 in
both cases) and a reduction in the number of mutants (Figure
4). These two cases of transmission ratio distortion have not
been investigated further but they do suggest that heterozy-
gosity for the MommeD mutations is associated with some
level of disadvantage. There also appears to be a skewed sex
ratio in the wild-type offspring of MommeD9 sires, suggest-
ing the phenotype of the father can affect his wild-type off-
spring. While we have not characterized this in any more
detail, the idea of a paternal effect is not new. We have previ-
ously published examples of paternal effects resulting from
haploinsufficiency of modifiers of epigenetic gene silencing in
the mouse [12].
Table 3
Embryo dissections to determine time of death of homozygotes
10.5 dpc 14.5 dpc 17.5/18.5 dpc
Name Normal Abnormal or resorbed Normal Abnormal or resorbed Normal Abnormal or resorbed
MommeD3 48 (60%) 32 (40%)*
MommeD3 (F1) 80 (74%) 28 (26%)* †
MommeD5 35 (74%) 12 (26%)* ‡ 42 (72%) 16 (28%)*
MommeD6 38 (63%) 22 (37%)* 25 (62.5%) 15 (37.5%)*
MommeD7 44 (85%) 8 (15%)§ 63 (74%) 22 (26%)
MommeD8 101 (94%) 7 (6%)
MommeD9 16 (64%) 9 (36%)* 19 (59%) 13 (41%)*
MommeD10 54 (93%) 4 (7%) 86 (88%)¶ 12 (12%)¥
Control cross 34 (94%) 2 (6%) 266 (93%) 19 (7%)
†The abnormal embryos from which DNA could be extracted (17) were genotyped across the linked interval and all shown to be MommeD3-/-. 
‡These abnormal (very small) embryos were genotyped and shown to be MommeD5-/-. ¶These normal embryos were genotyped and found to have 
the expected ratio of MommeD10+/+, MommeD10-/+ and MommeD10-/- embryos. ¥Four of the abnormal embryos were able to be genotyped: two 
were MommeD10-/+ and two were MommeD10-/-. *p < 0.0001; §p < 0.05.http://genomebiology.com/2008/9/12/R182 Genome Biology 2008,     Volume 9, Issue 12, Article R182       Ashe et al. R182.6
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Mapping
We have mapped the mutations in all ten cases to relatively
small regions of the genome (Table 4). The mapping of
MommeD1-D6 has been documented [10]. Here we report the
mapping of MommeD7-10. MommeD7 maps to a 0.25 Mb
region on chromosome 7 between markers D7Mit220 and
rs13479441 (using 134 phenotypically mutant and 135 pheno-
typically wild-type mice). This region contains 10 genes.
MommeD8 maps to a 4 Mb region on chromosome 4 between
markers rs6337795 and D4Mit279 (using 234 phenotypically
mutant and 177 phenotypically wild-type mice). This region
contains 54 genes. MommeD9 maps to a 3 Mb region on chro-
mosome 7 between markers rs31712695 and rs6193818
(using 103 phenotypically mutant and 127 phenotypically
wild-type mice). This region contains 80 genes. MommeD10
maps to a 4 Mb region between markers D5Mit165 and
rs13478547 on chromosome 5. Twenty-four phenotypically
homozygous and 312 phenotypically non-homozygous (het-
erozygous and wild-type mice combined) were used (see
Materials and methods). These data show that each of the ten
MommeD mutations maps to a unique region of the genome.
MommeD5 has a mutation in Histone deacetylase 1
MommeD5 was localized to a 1.42 Mb region on chromosome
4 flanked by the markers rs27486641 and rs27541967 [10]
(Table 4). This interval contains 46 genes and Hdac1 was cho-
sen as the best candidate because of its known role in chroma-
tin modification. Sequencing of all exons, including exon/
intron boundaries, from two heterozygous and two wild-type
individuals revealed a 7 bp deletion (GAAGCCA) in exon 13 in
the mutants (Figure 5a). This mutation was subsequently ver-
ified in over 100 mice classified as mutants by GFP expression
profiling. The chance of a second point mutation occurring in
a functional region in a linked interval of this size is extremely
small. Using the estimated mutation rate following ENU
mutagenesis of 1 in 1.82 Mb [15,16], the probability of such an
event can be calculated [15,17]. This website takes into
account the amount of coding sequence in a given linked
interval. In this case, the probability of a second point muta-
tion occurring in the coding region is p < 0.0005.
The mutation produces a frameshift, resulting in changes to
the last 12 amino acids, and an additional 25 amino acids.
Protein modeling predictions based on human HDAC8, for
which the crystal structure has been solved [18,19], suggest
that the carboxyl terminus of Hdac1 is relatively unstructured
and so the mutation is unlikely to affect the stability of the
protein (J Matthews, personal communication). An antibody
that recognizes the carboxyl terminus of Hdac1 showed a 50%
reduction of binding in 10.5 dpc MommeD5-/+ embryos, and
negligible binding in MommeD5-/- embryos (Figure 5b), con-
firming that this region of the protein has been altered in the
MommeD5 line. An antibody that recognizes the amino ter-
minus of Hdac1 showed that the levels of the protein are not
altered between mutant and wild-type mice (Figure 5b).
Lysine 476 at the carboxyl terminus has been shown to be
sumoylated and important for enzymatic function of the wild-
type protein [20] and the absence of this amino acid in the
MommeD5  mutant protein is likely to impair function. A
knockout of Hdac1 has been reported and the homozygous
embryos died around 9.5 dpc [21], similar to the time of death
Hematopoietic abnormalities in MommeD7 mice Figure 3
Hematopoietic abnormalities in MommeD7 mice. (a) Examples of 
phenotypically normal and abnormal (pale) embryos at 17.5 dpc. Abnormal 
embryos are assumed to be homozygous for MommeD7. Scale bar = 5 
mm. (b) Spleen weights from MommeD7+/+ and MommeD7-/+ adult mice. 
Error bars represent SEM. ***p < 0.0001. (c) Blood smears from 
MommeD7+/+ (left) and MommeD7-/+ (right) mice stained for reticulocytes 
(shown with arrowheads). (d) Representative histograms showing 
propidium iodide fluorescence in MommeD7+/+ (left) and MommeD7-/+ 
(right) mice. In each case 10,000 reticulocytes were counted. Red blood 
cells (RBC), reticulocytes (RET) and nucleated cells (NC) are shown. (e) 
Histogram showing relative levels of GFP fluorescence in red blood cells 
and reticulocytes. Averages were calculated from three wild-type and 
three heterozygous mice. **p < 0.005; error bars represent SEM.
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Table 4
Summary of MommeD screen for epigenetic modifiers
Name Suppressor or enhancer of variegation Mapping (Mb) Mutated gene, or number of genes in interval Homozygous lethality
MommeD1 Suppressor Chr 17 (2.4) SmcHD1* Females only E10
MommeD2 Suppressor Chr 9 (1.4) Dnmt1† E9
MommeD3 Suppressor Chr 11 (6) 123 E9-E14
MommeD4 Enhancer Chr 8 (2.5) Smarca5† E17
MommeD5 Enhancer Chr 4 (1.4) Hdac1 E8-E9
MommeD6 Suppressor Chr 14 (2.5) 32 E8-E9
MommeD7 Suppressor Chr 7 (0.25) 10 P1-P7
MommeD8 Enhancer Chr 4 (4) 54 Most P1-P21
MommeD9 Enhancer Chr 7 (4) 80 E9
MommeD10 Enhancer Chr 5 (4) Baz1b Most P1-P21
All mapping data are current for Ensembl build 37.1, release 49. *Reported in [11]. †Reported in [12].
Genotypes and sex of offspring, and litter size following paternal transmission of MommeD7-D10 Figure 4
Genotypes and sex of offspring, and litter size following paternal transmission of MommeD7-D10. (a) MommeD7, (b) MommeD8, (c) 
MommeD9, and (d) MommeD10 show the numbers of male and female offspring of wild-type (WT; black) and heterozygous (grey) genotype produced 
following a cross between a male heterozygous Momme and a wild-type female. MommeD9 and MommeD10 both show a trend towards transmission ratio 
distortion and a significant reduction in litter size compared to wild-type crosses. n represents the number of litters produced.
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observed in MommeD5-/-  embryos (Figure 5c). Together,
these results argue that the mutation in Hdac1 is causative of
the MommeD5 phenotype. Consistent with this, the level of
Hdac2 increased in both MommeD5-/+  and  MommeD5-/-
embryos, as predicted from the reports of compensatory
upregulation of Hdac2 in embryonic stem cells null for Hdac1
[21]. Indeed, this upregulation may explain why MommeD5
was identified as an enhancer, rather than a suppressor, of
variegation. Loss of histone deacetylase function is generally
associated with transcriptional activation, but exceptions to
this have been reported and the upregulation of Hdac2 could
explain these results [22].
MommeD10 has a mutation in Baz1b
MommeD10 was localized to a 4 Mb region on chromosome 5
flanked by the markers D5Mit165 and rs32250347 (Table 4).
Interestingly, this interval encompasses the region syntenic
with the Williams Beuren syndrome (WBS) critical region in
humans. WBS, also known as Williams syndrome, is an auto-
somal dominant disorder affecting approximately 1 in 10,000
individuals. The classic presentation of WBS includes a char-
acteristic craniofacial dysmorphology (elfin face), supraval-
vular aortic stenosis, multiple peripheral pulmonary arterial
stenoses, statural deficiency, infantile hypocalcaemia and a
distinct cognitive profile with mild mental retardation. The
linked interval for MommeD10 contains 52 genes and Baz1b
was chosen as the best candidate because it contains a bromo-
domain (a domain commonly associated with chromatin
remodelers) and has recently been shown to form at least two
chromatin remodeling complexes and associate with replica-
tion foci and promoters [23-25]. Sequencing of all exons,
including exon/intron boundaries, from two homozygous,
one heterozygous and one wild-type individual revealed one
point mutation (T  G transversion) in exon 7 in the mutants
(Figure 6a). This mutation was subsequently verified in over
100 mice classified as mutants by GFP expression profile. The
mutation results in a non-conservative amino acid change,
L733R, in a highly conserved region of the protein (Figure
6b). Western blot analysis showed reduced levels of Baz1b
protein in both embryonic and adult MommeD10-/- tissue,
with MommeD10-/+ tissue showing intermediate levels (Fig-
ure 6c and data not shown), suggesting that the mutant pro-
tein is much less stable than its wild-type counterpart.
Quantitative real-time PCR performed on cDNA from 14.5
dpc embryos showed all three genotypes have similar levels of
mRNA (Figure 6d).
A mutation in Hdac1 correlates with the MommeD5-/- phenotype Figure 5
A mutation in Hdac1 correlates with the MommeD5-/- phenotype. (a) A 7 bp deletion was detected in exon 13 of Hdac1. Representative 
chromatograms from the wild-type (WT) allele, the mutant allele, and one heterozygote are shown. This deletion alters the reading frame, changing the 
last 12 amino acids and adding 25 extra amino acids. (b) Whole-cell lysates from six individual 10.5 dpc MommeD5+/+ and MommeD5-/+ embryos, and six 
pooled MommeD5-/- embryos were probed with antibodies to the Hdac1 carboxyl terminus (top panel), Hdac2 (top panel) and Hdac1 amino terminus 
(bottom panel). Anti--tubulin was used as a loading control in each case. Quantification of the Hdac1 carboxyl terminus relative to -tubulin shows 
negligible binding in MommeD5-/- mice. Quantification of Hdac2 levels relative to -tubulin shows increased Hdac2 in MommeD5-/+ and MommeD5-/- 
embryos. Quantification of Hdac1 amino terminus relative to -tubulin shows equal levels of Hdac1 in all mice. A peptide blocking experiment was 
performed to confirm band identity. A representative western blot is shown. Error bars represent SEM. (c) A representative litter from a MommeD5-/+ 
intercross at 10.5 dpc. MommeD5-/- embryos (bottom right) are always dramatically smaller than MommeD5+/+ and MommeD5-/+ littermates.
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Effects of MommeD5 and MommeD10 on DNA 
methylation at the transgene locus
Transgene silencing can be associated with changes in both
DNA methylation [26,27] and chromatin accessibility [28].
This particular transgene promoter consists of a GC-rich seg-
ment of the human alpha-globin promoter, which we were
unable to analyze by bisulfite sequencing because the cloned
bisulfite converted fragment was refractory to growth in bac-
teria. The transgene also contains the HS-40 enhancer, which
is known to regulate the locus in humans [29]. We analyzed
the methylation state at this region by bisulfite sequencing. As
predicted from the variegated nature of the transgene expres-
sion, the methylation pattern differed from clone to clone in
all cases (data not shown). The percentage of methylated
CpGs in the HS-40 element was approximately 55% (aver-
aged across all clones) in spleen from 4-week-old wild-type
FVB/NJ mice (Figure 7a). Samples from MommeD5-/+,
MommeD10-/+, and MommeD10-/- mice showed similar lev-
els of CpG methylation (52%, 47%, 59% respectively; Figure
7a). Mice heterozygous for a null allele of Dnmt3b, which
showed an increase in expression of the GFP transgene from
37 ± 3% in the wild-type mice to 55.5 ± 2.5% in the Dnmt3b+/
- mice (in both cases mice were hemizygous for the transgene;
see Materials and methods), showed a decrease in CpG meth-
ylation at the HS-40 element (31%; Figure 7b) compared to
that seen in the wild-type C57BL/6J mouse strain (60%; Fig-
ure 7b). These data suggest that MommeD5 and MommeD10
mutants alter the expression of the transgene by changing the
chromatin state rather than by altering DNA methylation lev-
els. This is consistent with the fact that both genes encode
proteins involved in histone modification and chromatin
remodeling [21,23-25,30-33]. Modifiers identified in this
screen include DNA methyltransferases, chromatin remodel-
ers and genes involved in histone modification, all of which
have wide-ranging effects in the genome, making it difficult to
unravel direct and indirect effects at any particular locus.
Craniofacial analysis of MommeD10 mice
Surviving  MommeD10  homozygotes were significantly
smaller than littermates at weaning (Student's t-test,  p  <
0.0001; Figure 8a). A similar size differential was evident in
utero at 18.5dpc (Student's t-test, p < 0.01), indicating that
this is not simply due to poor post-natal feeding (Figure 8a).
MommeD10  homozygotes also appeared to have widened,
bulbous foreheads and shortened snouts (Figure 8b). To
examine the craniofacial phenotype more accurately, three
h e a d s  f r o m  4 - w e e k - o l d  m a l e  m i c e  o f  e a c h  g e n o t y p e
(MommeD10-/-,  MommeD10-/+  and  MommeD10+/+) were
subjected to micro-computed tomography. Heads from one
4-week-old female of each genotype were also examined at
this level. They followed the same trend as males. Visual
inspection of the three-dimensional reconstructions con-
firmed the original observation that homozygote's skulls were
more bulbous and showed a flattening of the nasal bone and
upward curvature of the nasal tip (Figure 8c).
Twenty cranial landmarks and nine mandibular landmarks
were located on each skull using approximately 70 micron
resolution datasets and inter-landmark measurements were
compared (Figure 8d and Additional data file 1). Statistical
analyses were carried out using the data collected from males
only. Homozygote skulls were significantly different to wild
A point mutation in Baz1b correlates with the MommeD10-/- phenotype Figure 6
A point mutation in Baz1b correlates with the MommeD10-/- phenotype. (a) A single base-pair mutation was detected in exon 7 of Baz1b. 
Representative chromatograms from one wild type, one heterozygote and one homozygote are shown. This results in a non-conservative amino acid 
change, L733R. (b) The MommeD10 point mutation (arrow) modifies an amino acid highly conserved across species (Hs, Homo sapiens; Mm, Mus musculus; 
Xl, Xenopus laevis; Gg, Gallus gallus; Dr, Danio rerio). (c) Whole-cell lysates from four 14.5 dpc heads of each genotype were probed with anti-Baz1b. Anti-
-tubulin was used as a loading control. Quantification of Baz1b relative to -tubulin shows negligible levels of Baz1b in MommeD10-/- mice. A 
representative western blot is shown. (d) Expression analysis by quantitative real-time RT-PCR was performed on mRNA prepared from 14.5 dpc heads. 
Levels of Baz1b mRNA were not affected by the mutation. Analysis was performed on three individuals of each genotype and normalized to two house-
keeping genes. Error bars in all graphs represent SEM.
(d)  (c)  
+/+      −/+      −/−
0
0.5
1
1.5
+/+ −/+ −/−
B
a
z
1
b
 
e
x
p
r
e
s
s
i
o
n
 
(
%
 
o
f
 
+
/
+
)
0.0
0.5
1.0
1.5
+/+ −/+ −/−
R
e
l
a
t
i
v
e
 
B
a
z
1
b
 
m
R
N
A
 
l
e
v
e
l
s
(b) 
Baz1b
γ-tubulin
(a) 
+/+ -/+ -/-http://genomebiology.com/2008/9/12/R182 Genome Biology 2008,     Volume 9, Issue 12, Article R182       Ashe et al. R182.10
Genome Biology 2008, 9:R182
type (Student's t-test, length:height ratio, p  < 0.01;
width:height ratio, p < 0.01; length:width ratio, p < 0.05),
confirming the bulbous appearance of the skulls on the recon-
structed images. Much of this difference could be attributed
to reduction of the parietal and nasal bones (both > 12.5%
shorter in homozygotes compared to an overall mean length
and width reduction of approximately 9%). The reduced pari-
etal bone length and the reduction and upward angulation of
the nasal bones in these mice (Figure 8c, d) are reminiscent of
the decrease in the volume of the parieto-occipital region and
the appearance of the nose in WBS patients [34,35]. Hetero-
zygotes also had a decreased cranium width:height ratio (Stu-
dent's  t-test,  p  < 0.05) and decreased length:height ratio
(Student's t-test, p < 0.05) compared to wild-type skulls. Of
note, heterozygotes showed a reduction in palatine bone
width of similar magnitude to that seen in homozygotes, sug-
gesting a greater sensitivity of some parts of the skull to
decreased Baz1b protein levels. Measurements of the lower
jaw revealed relative mandibular hypoplasia in homozygotes
that was most pronounced in the posterior region (approxi-
mately 20% reduction), encompassing the condyle, angle and
coronoid processes (Figure 8d and Additional data file 1). The
posterior aspects of the mandibles of heterozygotes were also
reduced in size when compared to wild-type mandibles, albeit
to a lesser degree than in the homozygotes.
Expression of Baz1b during mouse embryogenesis
It has previously been shown that Baz1b is expressed in the
mouse embryo from around 9.5 dpc and whole mount in situ
at 11.5 dpc showed expression in limb buds, tail and brain
[24]. We have gone on to characterize the expression of Baz1b
in more detail, and show that at 8.25 dpc Baz1b is expressed
in the headfolds, the caudal tail bud region and the presump-
tive hindbrain in a pattern reminiscent of rhombomere stain-
ing (Figure 9a, f). From 9.5 dpc expression is evident in the
somites and in the forelimb bud as it emerges from the lateral
plate mesoderm (Figure 9b). Diffuse mesenchymal expres-
sion in both the forelimb and hindlimb continues until 12.5
dpc when it is restricted to the interdigital mesenchyme (data
not shown).
In the facial primordia, Baz1b is expressed in branchial arch 1
as it first emerges (Figure 9g), and continues later in develop-
ment in both the maxillary and mandibular components of
branchial arch 1 and branchial arch 2 (Figure 9c-e, h, i).
Expression in the branchial arches is primarily mesenchymal,
Bisulfite analysis of the HS-40 enhancer element Figure 7
Bisulfite analysis of the HS-40 enhancer element. (a) DNA was extracted from the spleen of 4-week-old wild-type (FVB/NJ; three mice), 
MommeD5-/+ (three mice), MommeD10-/+ (three mice) mice and from the tail of MommeD10-/- mice (two mice). After bisulfite sequencing, the percentage 
of CpG methylation at each CpG site in the cloned region was analyzed, and averaged across individuals of the same genotype. None are significantly 
different from the wild-type mouse. Error bars represent SEM. (b) DNA was extracted from the tail of 4-week-old wild-type (C57BL/6; four mice) and 
Dnmt3b+/- (four mice) mice. After bisulfite sequencing, the percentage of CpG methylation at each CpG site in the cloned region was analyzed, and 
averaged across individuals of the same genotype. The Dnmt3b+/- mice have significantly (p < 0.001) less methylation than the wild-type mice. Error bars 
represent SEM.
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MommeD10-/- mice are smaller than their littermates and display craniofacial abnormalities Figure 8
MommeD10-/- mice are smaller than their littermates and display craniofacial abnormalities. (a) Body weight was measured for 46 
MommeD10+/+, 102 MommeD10-/+ and 10 MommeD10-/- weaners (3 weeks), and 11 MommeD10+/+, 22 MommeD10-/+ and 5 MommeD10-/- embryos (18.5 
dpc). Histograms show mean and SEM. (b) Craniofacial abnormalities in adult MommeD10-/- mice. MommeD10-/- mice display shorter snouts than age and 
sex-matched wild-type littermates. (c) Three-dimensional reconstruction of skull microCT data from 4-week-old male mice reveals distinct anomalies in 
homozygous Baz1B mice. Left side: lateral views show the overall size and shape of heterozygous skulls is similar to that of wild-type skulls, whereas skulls 
of homozygotes were around 20% shorter. Homozygous skulls showed variable anomalies, but consistently had a bulbous appearance, and a short, 
flattened, or upwardly angulated nasal bone (yellow arrowhead). Slight angulation of the nasal bones was also noted in one heterozygote. Right side: dorsal 
view of the homozygote skull shown on the left side showing the abnormal shape and more rostral connection of the zygomatic process with the 
squamosal bone (yellow arrow), skewing of the midline frontal bone suture (black arrow) and minor bilateral anomalies of the frontal:parietal suture (black 
arrowheads). (d) Twenty cranial landmarks and nine mandibular landmarks (based on those of Richtsmeier [49]) were located on each of nine skulls and 
inter-landmark measurements recorded. The mean value of each measurement, including analysis of cranium height:width and cranium length:height ratios, 
was compared between homozygous, heterozygous and wild-type animals.
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and is enriched in the rostral distal margin of the mandible,
and the caudal distal margin of branchial arch 2 (Figure 9c-e,
h). Baz1b is also expressed in the frontonasal process (Figure
9b) and later in the mesenchyme of both the medial and lat-
eral nasal prominences as they elevate to surround the nasal
pits (Figure 9c, d, h, i). Baz1b is expressed strongly in all the
major facial primordia from early in embryogenesis.
A possible role for Baz1b in Williams syndrome
Overall, the skull shape in mutant animals is reminiscent of
the head shape seen in WBS, including a small upturned nose
with flat nasal bridge, micrognathia (or mandibular hypopla-
sia), malocclusion, bi-temporal narrowing and prominent
forehead [34]. WBS is known to be associated with a
hemizygous deletion of approximately 28 genes in humans,
but which of these genes are responsible for the craniofacial
phenotype remains controversial. People with atypical dele-
tions, and varying degrees of craniofacial abnormalities,
implicate both proximal and distal ends of the deletion, sug-
gesting that more than one gene is responsible [36-41]. Tass-
abehji and colleagues [42] reported craniofacial defects in a
transgenic (c-myc; Tgf-) mouse line that harbored a chro-
mosomal translocation fortuitously disrupting the Gtf2ird1
gene, the human orthologue of which resides in the WBS crit-
ical interval [43]. Mice homozygous for this transgene pro-
duced little Gtf2ird1  mRNA and exhibited craniofacial
dysmorphism, suggesting a role for Gtf2ird1 in the craniofa-
cial phenotype. Mice hemizygous for the transgene were
indistinguishable from wild-type animals. Disruption of
Gtf2ird1 in this mouse was associated with a 40 kb deletion at
the site of integration, the addition of 5-10 tandem copies of a
c-myc transgene, and translocation of the entire segment to
chromosome 6 [43], providing opportunity for disruption to
the expression of other genes, such as Baz1b, in the region. A
targeted knockout of Gtf2ird1, produced by others, failed to
find craniofacial dysmorphology or dental abnormalities
[44]. We checked the sequence and expression of Gtf2ird1 in
MommeD10 mutants and found no abnormalities (data not
shown). The chance of a second point mutation occurring in a
coding region in this linked interval is extremely small (p =
0.0008, based on a mutation rate of 1 in 1.82 Mb) [15-17].
Our studies show that the chromatin remodeler Baz1b  is
expressed strongly in cranial neural crest-derived mesen-
chyme that drives facial morphogenesis and that homozygos-
ity for a missense mutation in Baz1b produces an array of
craniofacial features that are similar to those that character-
ize the typical WBS face. Significantly, some craniofacial fea-
tures are also apparent in heterozygotes. These results
suggest that reduction in Baz1b protein levels contributes to
the elfin facies characteristic of WBS and that WBS is, at least
in part, a chromatin-remodeling factor disease.
Conclusion
Extension of the screen has produced four new MommeDs,
MommeD7-D10, all of which behave in a semidominant fash-
ion, as do the six previously reported [10]. We have now iden-
tified the underlying genes in five of the ten cases, two of
which, Hdac1 and Baz1b, we report here. Both are already
known to be involved in epigenetic processes, further validat-
ing the screen design. In the case of Baz1b this is the first
report of a mouse carrying a disrupted allele at this locus and
we have shown a role for the protein in craniofacial develop-
ment.
The screen, designed primarily to identify genes involved in
the epigenetic gene silencing of foreign DNA, such as trans-
genes, has revealed the critical role that such genes play in
embryonic and fetal development. It is interesting that at
least half of the MommeDs are important during gastrulation.
Furthermore, the identification of heterozygous effects sug-
Whole mount in situ hybridization analysis in mouse embryos shows  expression in the developing facial prominences Figure 9
Whole mount in situ hybridization analysis in mouse embryos 
shows expression in the developing facial prominences. Embryos 
at a range of mid-gestational stages were hybridized with an antisense 
ribroprobe to the 3' untranslated region of Baz1b. (a-e) Views of whole 
embryos from 8.25-11.5 dpc reveal strong expression in the mesenchyme 
of the maxillary and mandibular prominences, branchial arch 2 and the 
nasal processes. Other sites of Baz1b expression include the presumptive 
hindbrain, headfolds and tailbud at 8.5 dpc, and the limb mesenchyme and 
somites at later stages. (f) Higher magnification dorsal view of 
presumptive hindbrain staining at 8.25 dpc. Close up images of facial 
prominence staining are shown at (g) 8.75 dpc, (h) 10.5 dpc, and (i) 11.5 
dpc. Images shown in (h, i) are ventral views following dissection of the 
head from the body of the embryo. BA1, branchial arch 1; BA2, branchial 
arch 2; Fl, forelimb; Fnp, frontonasal process; Hb, hindbrain; Hf, headfold; 
Hl, hindlimb; Lnp, lateral nasal prominence; Md, mandibular prominence; 
Mnp, medial nasal prominence; Mx, maxillary prominence; R, 
rhombomere; S, somite; Tb, tailbud.
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gests that a reduction in the amount of protein product of less
than 50% has effects on the health of the mouse. One of the
hallmarks of epigenetic gene silencing across all multicellular
organisms from plants to humans is the stochastic nature by
which they operate [45] and these studies re-emphasize the
importance of probabilistic events during embryogenesis. We
believe that this screen will provide new tools with which to
study these processes.
Materials and methods
Mouse strains
Wild-type inbred C57BL/6J and FVB/NJ mice were pur-
chased from ARC Perth. Procedures were approved by the
Animal Ethics Committee of the University of Sydney and the
Animal Ethics Committee of the Queensland Institute of
Medical Research. The ENU screen was carried out in the
FVB/NJ inbred transgenic line as described previously [10].
All  MommeD  lines were maintained in this strain unless
stated otherwise. Most crosses between MommeD individuals
were performed on individuals three generations or more
removed from the MommeD progenitor. A total of 1,000 G1
offspring were screened at 3 weeks of age, from which ten her-
itable dominant mutations were identified.
The Dnmt3b null mice were a kind gift from En Li. They have
been subsequently backcrossed for more than ten generations
to the C57BL/6J strain. GFP fluorescence in Dnmt3b+/- mice
was analyzed in the F1 offspring of crosses between Dnmt3b+/
- mice and the FVB/NJ transgenic line, and as such each
mouse was hemizygous for the transgene.
Flow cytometry
GFP fluorescence in erythrocytes was analyzed by flow
cytometry at weaning. A drop of blood was collected in Osmo-
sol buffer (Lab Aids Pty Ltd, Narrabeen, NSW, Australia) and
analyzed on a FACScan (Becton Dickinson, Franklin Lakes,
NJ, USA) with excitation at 488 and 550 nm. The 488 nm
channel predominantly measures GFP fluorescence and the
550 nm channel measures autofluoresence. The data were
analyzed using CELL QUEST software with a GFP-positive
gate set to exclude 99.9% of wild-type erythrocytes. Mean flu-
orescence was calculated using cells within the positive gate.
Histograms depict only the GFP fluorescence channel.
Genome walking
Genome walking was performed using the APAgene™ GOLD
Genome Walking Kit (Bio S&T Inc., Montreal, Quebec, Can-
ada) following the manufacturer's instructions. Gene specific
primers used were (5'-3'): WalkA CCATATTTTCACCATA-
CACGACA; WalkB GAGACTTTCTCATCCCCAAAACT; WalkC
CCCCAAAACTTGTACCCAAA.
Linkage analysis
For MommeD7, D8 and D9, FVB/C57 F1 heterozygous indi-
viduals were backcrossed to C57, and linkage analysis per-
formed on their offspring. Phenotype was assigned based on
GFP fluorescence profile. A panel of microsatellite markers
that differ in size between FVB and C57 were used to localize
the mutation to a small area of the genome. Mice wild type for
the mutation should only have C57 chromosomes at the
linked interval, while mice heterozygous for the mutation
should carry both FVB and C57 chromosomes.
Linkage analysis in MommeD10  was carried out using an
FVB/C57 F1 MommeD10-/+ intercross to produce 337 F2 indi-
viduals. MommeD10-/- mice were distinguished from their lit-
termates by their dramatically reduced size at weaning and
their reduced GFP expression profile. Recombination events
allowed the linked region to be localized to a small genomic
interval. MommeD10-/- mice should only carry FVB chromo-
somes at the MommeD10 linked region, while the remaining
mice should be either FVB/C57 or C57/C57.
Reticulocyte counts
Blood smears were made from blood taken from the tail tip of
MommeD7-/+ and MommeD7+/+ mice, and stained with New
methylene blue. Full blood analyses were done on the auto-
mated haematology analyzer Sysmex Xe-2100 (Sysmex Cor-
poration, Woodlands Spectrum, Singapore).
Reticulocyte analysis by FACS
Nucleated cells and reticulocytes were separated from mature
erythrocytes based on propidium iodide fluorescence levels.
An RNase control was performed and the presumptive retic-
ulocyte cell population could no longer be detected. Mean
GFP fluorescence was determined for reticulocyte and mature
erythrocyte cell populations. This was done essentially as
described in [46]. Three adult MommeD7-/+ and three wild-
type littermate controls were used. Approximately 25 l of
whole blood was collected from the tail in cold Osmosol buffer
(Lab Aids Pty Ltd). Cells were fixed for 1 h at 4°C in 1% para-
formaldehyde in Osmosol and t h e n  w a s h e d  o n c e  i n  c o l d
Osmosol. Cells were then permeabilized by adding -20°C eth-
anol to a cell pellet whilst vortexing, and incubated with rota-
tion for 2.5 h at 4°C. A 40 g/ml solution of propidium iodide
was added to pelleted cells and the cells were incubated at
37°C for 30 minutes. Analysis was performed on a FACScan
(Becton Dickinson). The data were analyzed using CELL
QUEST software.
Genotyping assay
Following identification of the MommeD10 point mutation,
genotyping was carried out by AciI digestion of a PCR product
of exon 7 of Baz1b (primers available on request). The AciI
site is created by the MommeD10 point mutation. Following
identification of the MommeD5  mutation, genotyping was
carried out by PCR amplification across the deleted region,
and gel electrophoresis using Ultra low-range agarose (Bio-
Rad, Hercules, CA, USA).http://genomebiology.com/2008/9/12/R182 Genome Biology 2008,     Volume 9, Issue 12, Article R182       Ashe et al. R182.14
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Protein analysis
We prepared whole-cell lysates of 10.5 dpc embryos
(MommeD5) and 14.5 dpc heads and adult spleen
(MommeD10) in 2-3× volume lysis buffer (0.05 M Tris, 7 M
urea, 150 mM NaCl). Samples were incubated on ice for 20
minutes, sonicated, centrifuged, and the supernatant col-
lected. Approximately 5 g (MommeD5) or 10 g
(MommeD10) of protein was separated by SDS-PAGE on a 4-
12% gradient gel (Invitrogen, Carlsbad, CA, USA) and was
analyzed with antibodies to the Hdac1 amino terminus (sc-
6299, Santa Cruz Biotechnology, Santa Cruz, CA, USA),
Hdac1 carboxyl terminus (05-100, Millipore, Billerica, MA,
USA), Hdac2 (05-814, Millipore), Baz1B (BL2067, Bethyl
Laboratories, Montgomery, TX, USA) or -tubulin (T5192,
Sigma-Aldrich, St Louis, MO, USA). Blots were quantified by
normalizing the levels of Hdac1, Hdac2 or Baz1B in each lane
to that of -tubulin. The normalized levels were then averaged
across genotypes and the ratio to wild-type levels calculated.
A peptide blocking experiment was carried out for the Hdac1
amino terminus using sc-6299P (Santa Cruz Biotechnology).
RNA preparation and quantitative RT-PCR
Total RNA was extracted from 14.5 dpc embryo heads using
TRI reagent (Sigma-Aldrich). cDNA was synthesized from
total RNA using SuperScriptII reverse transcriptase (Invitro-
gen) and random hexamer primers. Quantitative RT-PCR
was performed with the Platinum SYBR Green qPCR Super-
Mix-UDG with primers designed to span exon/intron bound-
aries (available on request). All reactions were performed in
triplicate and normalized to both GAPDH and ribosomal
highly basic 23-kDa protein (Rpl13A) [47]. The reaction was
run on a Corbett Research Rotor-Gene (Qiagen, Doncaster,
Vic, Australia).
Bisulfite sequencing of the transgene HS-40 enhancer
Bisulfite sequencing was carried out as described in [48]. Oli-
gonucleotides to the bisulfite converted HS-40 enhancer were
as follows (5'-3'): GFPbisF1 AAAATAAAATTTTTGGATTGT-
TATTATTATAA; GFPbisF2 ATATTTGTAATTTTAGTATTTT-
GGGAGGTT; and GFPbisR
AATCTCTACTCACTACAAACTCCATCTC. Cycling conditions
were as follows: 94°C for 2 minutes for 1 cycle; 94°C for 30 s,
60°C for 30 s, 72°C for 45 s for 35 cycles; and 72°C for 6 min-
utes for 1 cycle.
Micro-CT analysis
Three heads of 4-week-old male mice of each genotype, and
one head of female mice of each genotype (MommeD10-/-,
MommeD10-/+  and  MommeD10+/+) were scanned at 8.7
micron resolution using a SkyScan 1076 micro-computed
tomography unit and the data set reduced to approximately
17 microns for three-dimensional reconstruction of the serial
slices (CT Analyser software V.1.6.1.1; SkyScan, Kontich, Bel-
gium). Twenty cranial landmarks and nine mandibular land-
marks (based on those of Richtsmeier [49]) were located on
e a c h  o f  n i n e  s k u l l s  a n d  inter-landmark measurements
recorded using DataViewer software (V.1.3.0.0; SkyScan). To
verify accuracy of the measurements, any landmarks showing
marked differences between genotype groups were re-located
on a separate day and the measurement repeated. The mean
value of each measurement was compared between homozy-
gotes, heterozygotes and wild-type animals.
RNA probes and whole-mount in situ hybridization
DIG-labeled RNA probes were transcribed from linearized
DNA templates and used in whole mount in situ hybridization
analysis of wild-type FVB/NJ mouse embryos at a range of
gestational stages. The probe was directed to 1.1 kb of the 3'
untranslated region of Baz1b. A sense probe was used in ear-
lier experiments to confirm specificity of the antisense probe.
Whole mount in situ hybridization was performed as previ-
ously described [50]. Embryo images were captured digitally
using an Olympus SZX12 microscope with DP Controller soft-
ware (Olympus Corporation).
Abbreviations
dpc: days post-coitus; ENU: N-ethyl-N-nitrosourea; FACS:
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SEM: standard error of the mean; WBS: Williams Beuren
syndrome.
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